Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | School of Accounting and Finance | en_US |
| dc.contributor.advisor | Li, Qin (AF) | en_US |
| dc.contributor.advisor | Su, Nancy (AF) | en_US |
| dc.creator | Hu, Caixia | - |
| dc.identifier.uri | https://theses.lib.polyu.edu.hk/handle/200/13251 | - |
| dc.language | English | en_US |
| dc.publisher | Hong Kong Polytechnic University | en_US |
| dc.rights | All rights reserved | en_US |
| dc.title | Combating insider trading in the pharmaceutical industry : does FDA-mandated clinical trial disclosure provide a remedy? | en_US |
| dcterms.abstract | This paper examines the effect of mandatory clinical trial disclosures on the profits of insider trading, which is prevalent in the pharmaceutical industry. Using the implementation of the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which significantly increased the disclosure of clinical trials at Phase II or above, as an exogenous shock, I find a decrease in insider trading profits in affected firms. The cross-sectional analyses indicate that the effect is more pronounced for firms with higher uncertainty, poorer information environment, more detailed description of clinical trials, a higher degree of clinical trial completion, and an earlier submission of clinical trial results. Additionally, I find that the decrease in insider trading profits is concentrated among non-routine insider trades. These findings suggest that the increased disclosure under the FDAAA reduces the informational advantage of insiders and thus potentially constrains their profitable trading. My study highlights the importance of understanding the effectiveness of non-SEC disclosure regulations in deterring insider trading. | en_US |
| dcterms.extent | 45 pages : color illustrations | en_US |
| dcterms.isPartOf | PolyU Electronic Theses | en_US |
| dcterms.issued | 2024 | en_US |
| dcterms.educationalLevel | M.Phil. | en_US |
| dcterms.educationalLevel | All Master | en_US |
| dcterms.accessRights | open access | en_US |
Copyright Undertaking
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item:
https://theses.lib.polyu.edu.hk/handle/200/13251